Keel Point, LLC Abb Vie Inc. Transaction History

Keel Point, LLC

$1.12 Billion
Q2 2024

A detailed history of Keel Point, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Keel Point, LLC holds 9,169 shares of ABBV stock, worth $1.56 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

9,169

Previous 6,244 46.84%

Holding current value

$1.56 Million

Previous $1.14 Million 38.26%

% of portfolio

0.14%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $452,760 - $528,723	2,925 Added 46.84%	9,169 $1.57 Million
Q1 2024 Apr 16, 2024	BUY	$159.82 - $182.1 $71,119 - $81,034	445 Added 7.67%	6,244 $1.14 Million
Q4 2023 Jan 30, 2024	BUY	$137.6 - $154.97 $38,528 - $43,391	280 Added 5.07%	5,799 $898,000
Q3 2023 Oct 26, 2023	BUY	$133.59 - $154.65 $88,570 - $102,532	663 Added 13.65%	5,519 $822,000
Q2 2023 Jul 12, 2023	SELL	$132.51 - $164.9 $53,799 - $66,949	-406 Reduced 7.72%	4,856 $654,000
Q1 2023 Apr 03, 2023	BUY	$144.61 - $166.54 $230,363 - $265,298	1,593 Added 43.42%	5,262 $838,000
Q4 2022 Jan 17, 2023	BUY	$138.31 - $165.87 $91,699 - $109,971	663 Added 22.06%	3,669 $0
Q3 2022 Oct 05, 2022	BUY	$134.21 - $153.93 $3,221 - $3,694	24 Added 0.8%	3,006 $404,000
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $61,653 - $78,382	448 Added 17.68%	2,982 $420,000
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $10,690 - $13,263	81 Added 3.3%	2,534 $411,000
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $19,122 - $24,195	178 Added 7.82%	2,453 $332,000
Q3 2021 Nov 04, 2021	BUY	$106.4 - $120.78 $215,460 - $244,579	2,025 Added 810.0%	2,275 $245,000
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $220,414 - $245,554	-2,095 Reduced 89.34%	250 $751,000
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $210 - $234	2 Added 0.09%	2,345 $264,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $28,848 - $31,758	282 Added 13.68%	2,343 $254,000
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $165,889 - $223,968	2,061 New	2,061 $221,000
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $346,512 - $407,828	-4,492 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $88 - $98	1 Added 0.02%	4,492 $425,000
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $4,129 - $4,886	46 Added 1.03%	4,491 $416,000
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $180,983 - $242,354	-1,967 Reduced 30.68%	4,445 $421,000
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $80,604 - $88,389	-900 Reduced 12.31%	6,412 $620,000
Q3 2017 Nov 09, 2017	SELL	$69.85 - $89.22 $77,463 - $98,944	-1,109 Reduced 13.17%	7,312 $650,000
Q2 2017 Aug 15, 2017	BUY	N/A	8,421	8,421 $611,000

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account